Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2146/news180047 | DOI Listing |
Craniomaxillofac Trauma Reconstr
December 2024
Oral and Maxillofacial Surgery, 12 de Octubre University Hospital, Madrid, Spain.
BJR Open
January 2024
Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3BH, United Kingdom.
Adv Ther
November 2024
EVERSANA™, Burlington, ON, Canada.
Introduction: Indirect treatment comparisons (ITCs) evaluate novel treatments compared to appropriate comparators when direct evidence is unavailable or infeasible. The objective of this study was to highlight the prevalence of different ITC methods in oncology drug submissions and to provide insights into how ITCs have been used in recent regulatory approval, reimbursement recommendations, or pricing decisions across various regions and diverse assessment frameworks.
Methods: A targeted literature review was conducted to identify assessment documents for oncology drug submissions that included ITCs.
Plast Reconstr Surg Glob Open
March 2024
From the Department of Oral and Maxillofacial Surgery, Rambam Medical Care Center, Haifa, Israel.
Background: Comminuted fractures of the jaws are complex injuries requiring special attention. In the past, treatment included closed reduction using maxillomandibular fixation. With advancements in technology and fixation systems, open reduction became a prevalent option.
View Article and Find Full Text PDFJ Org Chem
April 2024
EnzyTag B.V, Daelderweg 9, 6361HK, Nuth, Netherlands.
Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many attractive targets are poorly tractable by small molecules, generating a need for new therapeutic modalities. Due to their biocompatibility profile and structural versatility, peptide-based therapeutics are a possible solution.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!